Pathway® Her-2/neu (4B5)
Company
Ventana Medical Systems, Inc.
Use
Assessment of breast cancer patients for whom Herceptin� treatment is considered.
Features
Second NIH licensed technology in an FDA approved product to be used in personalized medicine
NIH Contribution
Connection of HER2 gene with breast cancer.
HHS Institute/Agency
NCI
Inventor(s)
C. King
Year
1998
Tech Cat
Diagnostic
